ArticleJournal of hepatocellular carcinoma2026
Neoadjuvant Hepatic Arterial Infusion Chemotherapy with FOLFOX Plus Tislelizumab for Resectable Hepatocellular Carcinoma Beyond the Milan Criteria: Efficacy, Safety and Biomarker Exploration.
Quanwei Dai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.